Differential activities of secreted lymphotoxin-α3 and membrane lymphotoxin-α1β2 in lymphotoxin-induced inflammation: Critical role of TNF receptor 1 signaling

Journal of Immunology

Volumn 160, Issue 1, 1998, Pages 485-491

  Sacca, Rosalba ^a   Cuff, Carolyn A ^a   Lesslauer, Werner ^b   Ruddle, Nancy H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b F Hoffmann La Roche ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; INFLAMMATION; MEMORY CELL; MOUSE; NEPHRITIS; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL MEMBRANE; IMMUNOGLOBULINS; INFLAMMATION; INTEGRINS; KIDNEY; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUCOPROTEINS; PANCREAS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0031931573     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Paul, N. L., and N. H. Ruddle. 1988. Lymphotoxin. Annu. Rev. Immunol. 6:407.
2. Browning, J. L., A. Ngam-ek, P. Lawton, J. DeMarinis, R. Tizard, E. P. Chow, C. Hesson, B. O'Brine-Greco, S. F. Foley, and C. F. Ware. 1993. Lymphotoxin-beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847.
3. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-beta specific receptor. Science 264:707.
4. Browning, J. L., I. Douglas, A. Ngam-ek, P. R. Bourdon, B. N. Ehrenfels, K. Miatkowski, M. Zafari, A. M. Yampaglia, P. Lawton, W. Meier, C. P. Benjamin, and C. Hession. 1995. Characterization of surface lymphotoxin forms. J. Immunol. 154:33.
5. De Togni, P. D., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, J. H. Russell, R. Karr, and D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.
6. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. Kuklin, D. M. Bouley, J. Thomas, S. Kanangat, and M. L. Mucenski. 1995. Lymphotoxin-alpha-deficient mice: effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 144:1685.
7. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, and R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 6:491.
8. Pober, J. S., L. A. Lapierre, and A. H. Stolpen. 1987. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin-1 species. J. Immunol. 138:319.
9. Cavender, D. E., D. Edelbaum, and M. Ziff. 1989. Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am. J. Pathol. 134:551.
10. Barten, D., and N. H. Ruddle. 1993. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51:123.
11. Picarella, D., A. Kratz, C.-b. Li, N. H. Ruddle, and R. A. Flavell. 1992. Insulitis in transgenic mice expressing TNF-β (lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. USA 89:10036.
12. Kratz, A., A. Campos-Neto, M. S. Hanson, and N. H. Ruddle. 1996. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183: 1461.
13. Picarella, D. E., A. Kratz, C.-b. Li, N. H. Ruddle, and R. A. Flavell. 1993. Transgenic TNF-α production in islets leads to insulitis, not diabetes: distinct patterns of inflammation in TNF-α and TNF-β transgenic mice. J. Immunol. 149:4136.
14. Hochman, P. S., G. R. Majeau, F. Mackay, and J. L. Browning. 1996. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin. J. Inflamm. 46:220.
15. Mori, L., S. Iselin, G. De Libero, and W. Lesslauer. 1996. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor-1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J. Immunol. 157:3178.
16. Kalb, A., H. Bluethmann, M. W. Moore, and W. Lesslauer. 1996. Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics. J. Biol. Chem. 271:28097.
17. Beutler, B., and C. van Huffel. 1994. Unraveling function in the TNF ligand and receptor families. Science 264:667.
18. Vandenabeele, P., W. DeClercq, R. Beyaert, and W. Fiers. 1995. Two tumor necrosis factor receptors-structure and function. Trends Cell Biol. 5:392.
19. Pfeffer, K., T. Matsuyama, T. M. Kunding, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
20. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althaga, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
21. Erickson, S. L., F. J. D. Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. F. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour necrosis factor but normal T-cell development in TNF-receptor-2-deficient mice. Nature 372:560.
22. Barbara, J. A. J., W. B. Smith, J. R. Gamble, X. Van Ostade, P. Vandenabeele, J. Tavernier, W. Fiers, A. M. Vadas, and A. F. Lopez. 1994. Dissociation of TNF-α cytotoxic and proinflammatory activities by p55-receptor- and p75 receptor-selective TNF-α mutants. EMBO J. 13:843.
23. Mackay, F., J. Rothe, H. Bluethmann, H. Loetscher, and W. Lesslauer. 1994. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-α activation. J. Immunol. 153:5274.
24. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T. W. Mak, B. Holzmann, and M. Kronke. 1996. Crucial role of 55-kDa TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587.
25. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793.
26. Smith, C. A., T. Davis, D. Anderson, L. Solam, M. P. Beckmann, R. Jerzy, S. K. Dower, D. Cosman, and R. G. Goodwin. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019.
27. Tartaglia, L. A., M. Rothe, Y.-F. Hu, and D. V. Goeddel. 1993. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73:213.
28. Abitorabi, M. A., C. R. Mackay, E. H. Jerome, O. Osorio, E. C. Butcher, and D. J. Erle. 1996. Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph. J. Immunol. 156:3111.